Hospital Lymph Node Examination Rates and Survival After Resection for Colon Cancer | Colorectal Cancer | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.150.57. Please contact the publisher to request reinstatement.
1.
Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III colon cancer.  Ann Surg. 2006;244(4):602-61016998369Google Scholar
2.
Le Voyer TE, Sigurdson ER, Hanlon AL.  et al.  Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.  J Clin Oncol. 2003;21(15):2912-291912885809Google ScholarCrossref
3.
Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined.  Ann Surg Oncol. 2003;10(1):65-7112513963Google ScholarCrossref
4.
Bui L, Rempel E, Reeson D, Simunovic M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study.  J Surg Oncol. 2006;93(6):439-44516615148Google ScholarCrossref
5.
Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review.  J Natl Cancer Inst. 2007;99(6):433-44117374833Google ScholarCrossref
6.
National Quality Forum.  Specifications of the national voluntary consensus standards for breast and colon cancer. http://www.qualityforum.org/pdf/cancer/txbreast-colonAppA-Specsvoting01-18-07clean.pdf. Accessibility verified October 9, 2007
7.
 National Quality Forum endorsed commission on cancer measures for quality of cancer care for breast and colorectal cancers [press release]. Chicago, IL: American College of Surgeons Commission on Cancer; April 12, 2007
8.
Canessa CE, Badia F, Fierro S, Fiol V, Hayek G. Anatomic study of the lymph nodes of the mesorectum.  Dis Colon Rectum. 2001;44(9):1333-133611584211Google ScholarCrossref
9.
Pagès F, Berger A, Camus M.  et al.  Effector memory T cells, early metastasis, and survival in colorectal cancer.  N Engl J Med. 2005;353(25):2654-266616371631Google ScholarCrossref
10.
Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.  Med Care. 2002;40(8):(suppl)  IV3-IV1812187163Google Scholar
11.
World Health Organization.  International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977
12.
Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data.  Med Care. 1998;36(1):8-279431328Google ScholarCrossref
13.
Warren JL, Harlan LC, Fahey A.  et al.  Utility of the SEER-Medicare data to identify chemotherapy use.  Med Care. 2002;40(8):(suppl)  IV55-IV6112187169Google Scholar
14.
Lin DY. Cox regression analysis of multivariate failure time data: the marginal approach.  Stat Med. 1994;13(21):2233-22477846422Google ScholarCrossref
15.
Ostadi MA, Harnish JL, Stegienko S, Urbach DR. Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens [published online ahead of print May 24, 2007].  Surg Endoscdoi:10.1007/s00464-007-9414-617522917Google Scholar
16.
Rieger NA, Barnett FS, Moore JW.  et al.  Quality of pathology reporting impacts on lymph node yield in colon cancer.  J Clin Oncol. 2007;25(4):46317264350Google ScholarCrossref
17.
Kelder W, Inberg B, Plukker JT, Groen H, Baas PC, Tiebosch AT. Effect of modified Davidson's fixative on examined number of lymph nodes and TNM-stage in colon carcinoma [published online ahead of print June 8, 2007].  Eur J Surg Oncoldoi:10.1016/j.ejso.2007.04.01217561364Google Scholar
18.
Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery.  Ann Surg. 2007;245(5):777-78317457171Google ScholarCrossref
19.
Porter GA, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer.  Ann Surg. 1998;227(2):157-1679488510Google ScholarCrossref
20.
Schrag D, Cramer LD, Bach PB, Cohen AM, Warren JL, Begg CB. Influence of hospital procedure volume on outcomes following surgery for colon cancer.  JAMA. 2000;284(23):3028-303511122590Google ScholarCrossref
21.
Schrag D, Panageas KS, Riedel E.  et al.  Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection.  Ann Surg. 2002;236(5):583-59212409664Google ScholarCrossref
22.
National Cancer Institute.  Cancer of the colon and rectum. http://seer.cancer.gov/statfacts/html/colorect.html?statfactspage=colorect.html&x=18&y=19. Accessibility verified October 9, 2007
Original Contribution
November 14, 2007

Hospital Lymph Node Examination Rates and Survival After Resection for Colon Cancer

Author Affiliations
 

Author Affiliations: Michigan Surgical Collaborative for Outcomes Research and Evaluation, Departments of Surgery (Drs Wong, Morris, Baser, Birkmeyer, and Ms Ji) and Urology (Dr Hollenbeck), University of Michigan, Ann Arbor.

JAMA. 2007;298(18):2149-2154. doi:10.1001/jama.298.18.2149
Abstract

Context Several studies suggest improved survival among patients in whom a higher number of nodes are examined after colectomy for colon cancer. The National Quality Forum and other organizations recently endorsed a 12-node minimum as a measure of hospital quality.

Objective To assess whether hospitals that examine more lymph nodes after resection for colon cancer have superior late survival rates.

Design, Setting, and Patients Retrospective cohort study, using the national Surveillance, Epidemiology, and End Results (SEER)–Medicare linked database (1995-2005), of US patients undergoing colectomy for nonmetastatic colon cancer (n = 30 625). Hospitals were ranked according to the proportion of their patients in whom 12 or more lymph nodes were examined and then were sorted into 4 evenly sized groups. Late survival rates were assessed for each hospital group, adjusting for potentially confounding patient and clinician characteristics.

Main Outcome Measures Hospitals' lymph node examination rates in association with cancer staging, use of adjuvant chemotherapy (indicated for patients with node-positive disease), and 5-year survival rate.

Results Hospitals with the highest proportions of patients with examination of 12 or more lymph nodes tended to treat lower-risk patients and had substantially higher procedure volumes. After adjusting for these and other factors, there remained no statistically significant relationship between hospital lymph node examination rates and survival after surgery (adjusted hazard ratio, highest vs lowest hospital quartile, 0.95; 95% confidence interval, 0.88-1.03). Although the 4 hospital groups varied widely in the number of lymph nodes examined, they were equally likely to find node-positive tumors and had very similar overall unadjusted rates of adjuvant chemotherapy (26% vs 25%, highest vs lowest hospital quartile).

Conclusions The number of lymph nodes hospitals examine following colectomy for colon cancer is not associated with staging, use of adjuvant chemotherapy, or patient survival. Efforts by payers and professional organizations to increase node examination rates may have limited value as a public health intervention.

×